AR and breast carcinoma: We recently reported the expression of AR variant transcripts and proteins (e.g., AR-V7) in breast cancer cell lines and breast cancer tissues, highlighting a potential role of AR variants in mediating resistance to antiandrogen therapy in breast cancer [9,19].